Kamada director granted 30,000 stock options

Kamada Ltd reported that director Uri Botzer received a grant of 30000.0000 Employee Stock Options to purchase Ordinary Shares at an exercise price of $7.5200 per share, translated from NIS using the Bank of Israel rate as of August 4, 2026.

Rhea-AI Filing Summary

Kamada Ltd reported that director Uri Botzer received a grant of 30000.0000 Employee Stock Options to purchase Ordinary Shares at an exercise price of $7.5200 per share, translated from NIS using the Bank of Israel rate as of August 4, 2026. The options vest in four equal 25% annual installments, are exercisable for 10 years from the grant date, and any unexercised options then expire. The award is held indirectly by a trustee under the company’s 2011 Share Award Plan.

Insider Trade Summary

Grant/Award: 30,000 shares

Grant/Award 1 txn

Insider Botzer Uri

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy) F1, F2, F3	30,000	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 30,000 contracts (Indirect, Held by trustee)

Footnotes (3)

1. F1. The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.
2. F2. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.
3. F3. Held by trustee under the Company's 2011 Share Award Plan.

Key Figures

Options granted: 30000.0000 options Exercise price: $7.5200 per share Underlying Ordinary Shares: 30000.0000 shares +2 more

5 metrics

Options granted 30000.0000 options Employee Stock Option grant to director Uri Botzer on 2026-08-05

Exercise price $7.5200 per share Exercise price for the options, presented in U.S. dollars converted from NIS

Underlying Ordinary Shares 30000.0000 shares Ordinary Shares underlying the Employee Stock Options granted to Uri Botzer

Annual vesting portion 25% Portion of options that vests on each anniversary of the grant date over four years

Option term 10 years Period during which the options are exercisable following the grant date

Key Terms

Employee Stock Option (right to buy), exercise price, vest, Share Award Plan

4 terms

Employee Stock Option (right to buy) financial

"Security title listed as Employee Stock Option (right to buy)"

exercise price financial

"The exercise price presented in U.S. dollars represent a convenience"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest financial

"The options will vest over a period of four years"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Share Award Plan financial

"Held by trustee under the Company's 2011 Share Award Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity award did Kamada (KMDA) report for director Uri Botzer?

Kamada reported that director Uri Botzer received 30000.0000 Employee Stock Options to purchase Ordinary Shares. The options are compensation, not a share sale, and provide potential future ownership if exercised under the stated terms.

What is the exercise price of Uri Botzer’s Kamada (KMDA) stock options?

The options have an exercise price of $7.5200 per share. This amount is presented in U.S. dollars as a convenience conversion from NIS, using the exchange rate published by the Bank of Israel as of August 4, 2026.

How do Uri Botzer’s Kamada (KMDA) stock options vest over time?

The options vest over four years in four equal installments. 25% of the options vest on each anniversary of the grant date, creating a gradual vesting schedule that ties the award to continued service during the four-year period.

How long are Uri Botzer’s Kamada (KMDA) stock options exercisable?

The options are exercisable for a period of 10 years following the grant date. After this 10-year term, any options that remain unexercised will expire immediately, meaning they can no longer be converted into Ordinary Shares.

How many Ordinary Shares underlie Uri Botzer’s Kamada (KMDA) option grant?

The grant covers 30000.0000 Ordinary Shares as the underlying security. Each Employee Stock Option represents the right to buy one Ordinary Share at the stated exercise price, subject to vesting and the 10-year exercisability period.

Are Uri Botzer’s Kamada (KMDA) options held directly or through a trustee?

The options are held indirectly by a trustee under the company’s 2011 Share Award Plan. This means the reporting person’s interest in the award is noted as “Held by trustee,” rather than being recorded as directly held in his own name.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 07:00 AM Accepted by SEC EDGAR 08/06/2026 - 07:00 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Botzer Uri

(Last) (First) (Middle)

94 YIGAL ALON ST., ALON TOWER 2.

(Street)

TEL AVIV

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$7.52(1)	08/05/2026		A		30,000		(2)	(2)	Ordinary Shares	30,000	$0.00	30,000	I	Held by trustee(3)

Explanation of Responses:

1. The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.

2. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

3. Held by trustee under the Company's 2011 Share Award Plan.

	/s/ Uri Botzer	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)